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Aneuploidy—or an unbalanced karyotype in which whole chromosomes are gained or lost—causes reduced fitness
at both the cellular and organismal levels but is also a hallmark of human cancers. Aneuploidy causes a variety of
cellular stresses, including genomic instability, proteotoxic and oxidative stresses, and impaired protein trafficking.
The deubiquitinaseUbp3, whichwas identified by a genome-wide screen for gene deletions that impair the fitness of
aneuploid yeast, is a key regulator of aneuploid cell homeostasis. We show that deletion of UBP3 exacerbates both
karyotype-specific phenotypes and global stresses of aneuploid cells, including oxidative and proteotoxic stress.
Indeed, Ubp3 is essential for proper proteasome function in euploid cells, and deletion of this deubiquitinase leads
to further proteasome-mediated proteotoxicity in aneuploid yeast. Notably, the importance of UBP3 in aneuploid
cells is conserved. Depletion of the human homolog of UBP3, USP10, is detrimental to the fitness of human cells
upon chromosome missegregation, and this fitness defect is accompanied by autophagy inhibition. We thus used a
genome-wide screen in yeast to identify a guardian of aneuploid cell fitness conserved across species. We propose
that interfering with Ubp3/USP10 function could be a productive avenue in the development of novel cancer
therapeutics.
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Aneuploidy—or an unbalanced karyotype in which whole
chromosomes are gained or lost—results from chro-
mosome missegregation during mitotic or meiotic cell
divisions. Such genomic imbalance causes a variety of
phenotypes on both the cellular and organismal levels
and is the leading cause of spontaneous abortion in hu-
mans. Whole organisms with constitutional aneuploidy
are generally less fit than their euploid counterparts and
exhibit developmental abnormalities as well as reduced
viability or longevity. Interestingly, however, themajority
of human cancer cells is also aneuploid, with >90% of sol-
id tumors exhibiting some degree of genomic imbalance
(Weaver and Cleveland 2006; Nagaoka et al. 2012).
Aneuploid cells, regardless of origin, are known to
express the vast majority of the genes encoded on their
extra chromosomes at both the RNA and protein levels
(Mao et al. 2003; Torres et al. 2007; Williams et al. 2008;
Pavelka et al. 2010; Stingele et al. 2012; Dephoure et al.
2014). The expression of these extra proteins leads to a
plethora of phenotypes in aneuploid yeast cells, including
impaired proliferation, genomic instability, vesicle trans-
port defects, and proteotoxic and oxidative stresses among
others (Torres et al. 2007; Sheltzer et al. 2011; Oromendia
et al. 2012; Dephoure et al. 2014; Dodgson et al. 2016).
These phenotypes are thought to be caused primarily by
the sum of many gene imbalances that, on their own,
have little or no phenotype, as copy number changes of in-
dividual dosage-sensitive genes cannot explain the prolif-
eration defects of aneuploid yeast (Torres et al. 2007;
Pavelka et al. 2010; Oromendia et al. 2012; Bonney et al.
2015). However, particular aneuploidies have been shown
to cause chromosome-specific phenotypes, indicating
that the consequences of aneuploidy represent a combi-
nation of the overall genomic imbalance as well as the
results of specific gene duplications or deletions (Torres
et al. 2007; Pavelka et al. 2010; Chen et al. 2015; Dodgson
et al. 2016).
Proteins must be properly folded and assembled into
complexes with balanced stoichiometries. If this does
not occur, proteins are degraded. The processes of protein
folding, complex assembly, and degradation are mediated
by chaperones and the ubiquitin–proteasome system
(UPS). Aneuploid yeast cells are sensitive to compounds
that interfere with protein folding and degradation,
Corresponding author: angelika@mit.edu
Article published online ahead of print. Article and publication date ate
online at http://www.genesdev.org/cgi/doi/10.1101/gad.287474.116.
© 2016 Dodgson et al. This article is distributed exclusively by Cold
Spring Harbor Laboratory Press for the first six months after the full-issue
publication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).
After six months, it is available under a Creative Commons License
(Attribution-NonCommercial 4.0 International), as described at http://
creativecommons.org/licenses/by-nc/4.0/.
GENES & DEVELOPMENT 30:2259–2271 Published by Cold Spring Harbor Laboratory Press; ISSN 0890-9369/16; www.genesdev.org 2259
 Cold Spring Harbor Laboratory Press on November 3, 2017 - Published by genesdev.cshlp.orgDownloaded from 
suggesting that aneuploidy places a burden on these path-
ways (Torres et al. 2007; Oromendia et al. 2012). Similarly,
aneuploid mammalian cells are sensitive to chaperone
and autophagy inhibitors, indicating that limited protein
quality control pathway function is a universal feature
of the aneuploid state (Tang et al. 2011; Donnelly et al.
2014).
We previously conducted a genome-wide screen for
genes whose deletion specifically impairs the fitness of
aneuploid Saccharomyces cerevisiaeusing haploid strains
containing single extra chromosomes, known as disomes
(Dodgson et al. 2016). The deletion of one gene, UBP3,
encoding a deubiquitinating enzyme (DUB) was found to
be detrimental to the growth ofmost disomic yeast strains
analyzed. Here we investigate the mechanism of this
synthetic fitness defect and identify both chromosome-
specific and global weaknesses of aneuploid cells exacer-
bated by deletion of UBP3. The aneuploidy-wide effects
of UBP3 deletion can be explained by the observation
thatUbp3 is required for efficientUPS function,with dele-
tion of this gene impairing protein degradation in both
euploid and aneuploid cells. We further demonstrate
that the anti-proliferative effect conferred by UBP3 dele-
tion on aneuploid cells is conserved in higher eukaryotes.
Depletion or inhibition of the human homologUSP10 re-
duces aneuploid human cell fitness. We conclude that
pleiotropic hub proteins such as Ubp3 act as aneuploidy-
tolerating proteins and that interference with such pro-
teins affects aneuploid cell viability across species.
Results
Deletion of UBP3 broadly impairs aneuploid budding
yeast cell fitness
Using synthetic genetic array (SGA) analysis, we previous-
ly generated a data set of synthetic fitness interactions
between gene deletions and the condition of yeast aneu-
ploidy (Dodgson et al. 2016). The deletion ofUBP3 exhib-
ited among the most severe synthetic negative fitness
interactions with all disomes queried in high-throughput
screens of the yeast knockout collection (overall rank =
11) (Fig. 1A). We confirmed this synthetic fitness defect
by de novo deletion ofUBP3 in the yeast disomes. Colony
sizes of disomic yeast deleted for UBP3 upon dissection
were substantially reduced relative to euploid counter-
parts (Fig. 1B). Additionally, the proliferation rates of the
disomes lacking UBP3 are, in most cases, much slower
than that of a euploid ubp3Δ strain (Fig. 1C). In fact,
Figure 1. Deletion of UBP3 impairs the proliferation of aneu-
ploid yeast cells. (A) The SGA ranks of the UBP3 deletions in
terms of fitness defect conferred on each disome are plotted at
the left. The distribution of all gene ranks across the seven diso-
mic SGA screens is plotted at the right for comparison. The dis-
tributions are significantly different. P < 0.0001, Mann-Whitney
test. Data from are from Dodgson et al. (2016). (B) Euploid
ubp3Δ cells were crossed to each disome and dissected to gener-
ate ubp3Δ disomic strains. Resulting colony size ratios (ubp3Δ/
UBP3) for each disome and the euploid control are shown. (∗) P
< 0.05; (∗∗∗) P < 0.001; (∗∗∗∗) P < 0.0001, Student’s t-test. Colony
size ratios equal to zero are indicative of synthetic lethality. (C )
Doubling times of disomes either wild type (WT) or deleted for
UBP3were determined by growing cells in YPD at 25°C and tak-
ing OD600measurements every 15min over 24 h. SD is shown. (∗)
P < 0.05; (∗∗) P < 0.001, Student’s t-test. Disomes are ordered by in-
creasing size of the extra chromosome.Doubling timesmarked as
infinite (∞) represent synthetic lethality. (D) The proliferation
defect (ubp3Δ/UBP3) relative to the euploid control is plotted
as a function of the number of ORFs encoded on the disomic chro-
mosome. Linear regression analysis gives an r2 value of 0.47 (r2 =
0.81 if disomeXIII is excluded). (E) Triploid strains of S. cerevisiae
containing either three (wild-type) or zero (ubp3Δ) copies ofUBP3
were induced to sporulate. The resulting tetrads were dissected,
and the number of spores that formed colonies was counted. n
= 3 biological replicates of 80 dissected spores. χ2 test, df = 1; P =
0.0024. (F ) Cultures of the indicated strains were grown overnight
in YPD, and 10-fold serial dilutions were plated on YPD plates at
the indicated temperatures.
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disomy for either chromosome XII or XIV is synthetic le-
thal with deletion ofUBP3; such strains cannot be recov-
ered without loss of large segments of the disomic
chromosome or whole-genome-doubling events, which
buffer against the adverse effects of aneuploidy (data not
shown). The degree of this synthetic fitness defect corre-
lates to some extent with the amount of extra genetic ma-
terial present in aneuploid cells, with strains containing
larger extra chromosomes tolerating UBP3 deletion
more poorly (Fig. 1D). This is true for both the colony
size and doubling time measurements, although we note
that the two do not correspond perfectly, likely due to
the impact of additional parameters such as germination
and growth in the absence of a quorum influencing colony
size. Importantly, the synthetic defect is not a function
solely of the slow growth of disomic yeast, as deletion of
UBP3 did not impair the proliferation of slow-growing
temperature-sensitive cdc mutants (Supplemental Fig.
S1).
Deletion ofUBP3 not only impaired the fitness of diso-
mic yeast strains, it was also detrimental in other yeast
aneuploidy models. When triploid yeast strains are in-
duced to undergo meiosis, the resultant spores harbor
karyotypes ranging from euploid to highly aneuploid
(Charles et al. 2010). For this reason, spore viability of trip-
loid yeast is very low; however, deletion of all three copies
ofUBP3 in a triploid strain further reduced spore viability,
demonstrating incompatibility with the aneuploid cell
state (Fig. 1E). Furthermore, deletion of UBP3 exhibits
a synthetic genetic defect with mutations that cause in-
creased chromosome missegregation. Temperature-sen-
sitive mutations in genes essential for chromosome
segregation are lethal at the restrictive temperature (37°
C), but, when cells with mutations in these genes are
grown at intermediate (semipermissive) temperatures,
these strains are viable but missegregate chromosomes
at a high rate, leading to the accumulation of aneuploid
cells (Oromendia et al. 2012). We found that the growth
defects of strains harboring the temperature-sensitive
mutations ipl1-321 or ndc10-1 were exacerbated by dele-
tion of UBP3 at semipermissive temperatures (Fig. 1F).
We conclude that deletion of UBP3 causes broad fitness
impairment of aneuploid cells of various origins and
karyotypes.
Deletion of UBP3 specifically impairs vesicle transport
in disome XVI cells
UBP3 encodes a highly pleiotropic DUB that removes
monoubiquitin from substrates (Baker et al. 1992; Brew
and Huffaker 2002). Due to the diversity of its substrates,
the deletion ofUBP3 has been implicated in a plethora of
cellular processes, including vesicle transport, proteosta-
sis, stress granule formation, the response to DNA dam-
age, and autophagy (Baxter and Craig 1998; Cohen et al.
2003a; Bilsland et al. 2007; Oling et al. 2014; Müller
et al. 2015; Nostramo et al. 2016). It was therefore plausi-
ble that deletion ofUBP3had a variety of consequences on
aneuploid cells either dependent on or independent of kar-
yotype. That is, UBP3 deletion may impair disomic fit-
ness through different pathways in each disomic strain,
through a global mechanism common among aneuploid
cells, or through a combination of both.
We showed previously that aneuploidy impairs vesicle
transport in most disomic yeast strains (Dodgson et al.
2016). Given the role of Ubp3 in this process (Cohen
et al. 2003a,b), we examined secretion of the glycoprotein
Ccw14 in disomes lacking UBP3. In wild-type cells,
Ccw14 becomes covalently attached to the yeast inner
cell wall and is therefore insoluble and mostly undetect-
able inWestern blots (Fig. 2A; Dodgson et al. 2016). Accu-
mulation of Ccw14 in either its faster-migrating ER form
or its slower-migrating post-Golgi form indicates the pres-
ence of secretory delays. Deletion of UBP3 resulted in
clear secretory defects at multiple steps in the pathway
across all ubp3Δ strains tested (Fig. 2A). However, these
defects were exacerbated only in the disome XVI ubp3Δ
strain. Accumulation of the ER form of Ccw14 was as ex-
treme in disome XVI ubp3Δ cells as in a known secretory
mutant, sec7-1 (Fig. 2A). Thus, deletion ofUBP3 causes a
chromosome-specific vesicle-trafficking defect in disome
XVI cells.
We next attempted to determine whether the traffick-
ing defect of disome XVI ubp3Δ cells could be traced
to duplication of a specific gene on chromosome XVI. A
known chromosome XVI-encoded dosage-sensitive gene
involved in Golgi function is KES1 (Fairn et al. 2007).
Restoration of haploid KES1 gene dosage in disome XVI
Figure 2. Deletion of UBP3 enhances the vesicle transport
defect of disome XVI cells. (A) Cells were grown to mid-log phase
in YPD at room temperature. Ccw14 mobility was analyzed by
Western blot analysis. The ER and post-Golgi forms of the protein
are indicated. Known secretory mutants sec6-4 and sec7-1 are
shown for comparison. Pgk1 was used as a loading control. The
lysates for the blot at the left (disomes wild type [WT] for
UBP3) are from Dodgson et al. (2016). (B,C ) Doubling times of
the indicated strains were determined as described in Figure 1.
(∗∗∗) P < 0.0001, Student’s t-test. (D) Cultures of the indicated
strains were grown overnight in YPD, and 10-fold serial dilutions
were plated on YPD plates with or without the indicated concen-
tration of Brefeldin A at 30°C.
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ubp3Δ partially suppressed the proliferation defect of
these cells (Fig. 2B). Consistent with this observation,
we found that euploid cells lacking UBP3 are sensitive
to the duplication of KES1; introduction of a centromeric
plasmid harboring the KES1 gene increased the doubling
time of the ubp3Δ strain while having little effect on
wild type (Fig. 2C). Restoration of euploid KES1 dosage
also partially rescued the increased sensitivity of the dis-
ome XVI ubp3Δ strain to the vesicle transport-inhibiting
drug Brefeldin A (Fig. 2D). However, although duplication
of KES1 partially explains the fitness defect conferred
by deletion of UBP3 on disome XVI, it does not explain
the severe Ccw14 secretion defect of disome XVI ubp3Δ
cells. Disome XVI ubp3Δ cells carrying only one copy of
the KES1 gene behaved indistinguishably from disome
XVI ubp3Δ cells with two copies of KES1 in the Ccw14
secretion assay (Supplemental Fig. S2). Our results indi-
cate that duplication of KES1 contributes to the extreme
protein-trafficking defect in these cells, albeit without
affecting Ccw14 secretion. We conclude that chromo-
some-specific phenotypes explain at least part of the
fitness defects conferred by deletion of UBP3 on the di-
somic strains. Thus, karyotype is an important determi-
nant of the magnitude of the response of aneuploid cells
to even broadly detrimental mutations.
Proteotoxic stress is increased in disomic yeast strains
lacking UBP3
In addition to chromosome-specific phenotypes, the dis-
omes share cellular stresses such as genomic instability,
proteotoxic stress, and oxidative stress (Sheltzer et al.
2011; Oromendia et al. 2012; Dephoure et al. 2014).
UBP3 was originally isolated as a multicopy suppressor
of a heat-shock response-defective mutant and has since
been shown to contribute to protein aggregate clearance
in proteotoxically stressed cells (Baxter and Craig 1998;
Oling et al. 2014). Indeed, disomes lacking UBP3 are par-
ticularly heat-sensitive, with ubp3Δ disomes VIII, IX, XI,
XV, and XVI showing large doubling time increases at
37°C (Supplemental Fig. S3). Given the high levels of pro-
teotoxicity exhibited by disomic yeast, we assessed the
effect of UBP3 deletion on this phenotype using the pre-
viously described proteotoxicity reporter VHL-GFP (Kaga-
novich et al. 2008; Oromendia et al. 2012). The expression
of human VHL in yeast in the absence of its binding part-
ners, Elongin B and Elongin C, leads to its ubiquitination
and degradation (McClellan et al. 2005; Kaganovich et al.
2008). In proteotoxically stressed cells, however, VHL is
prone to form aggregates, which are visible as VHL-GFP
foci. Using this assay, we observed a substantial increase
in the number of disomic cells with discernible VHL-
GFP foci under unstressed conditions (Fig. 3A). Remark-
ably, deletion of UBP3 caused such significant proteo-
toxic stress in the disomes that a notable fraction of
ubp3Δ cells contained more than one VHL-GFP focus, an
event rarely observed in wild-type cells (Fig. 3B). The ex-
tent of this severe proteotoxicity, defined as the number
of cells containing multiple VHL-GFP foci, correlated
strongly with the fitness defect conferred by deletion of
UBP3 (Fig. 3C). This observation suggests that the proteo-
toxic stress exacerbated by UBP3 deletion in aneuploid
yeast contributes significantly to the fitness impairment
brought about by the deletion of this DUB gene, and we
postulate that the proteotoxicity conferred byUBP3 dele-
tion on the disomes exceeds a threshold tolerable for nor-
mal cell growth and viability.
In addition to aggregate clearance, Ubp3 has been re-
ported to play roles in multiple types of autophagy (Kraft
et al. 2008; Kelly and Bedwell 2015; Müller et al. 2015).
Figure 3. Deletion ofUBP3 exacerbates proteotoxic-
ity in disomic yeast strains. (A,B) Euploid (wild type
[WT]) and disomic yeast strains wild type or deleted
for UBP3 and expressing a VHL-GFP fusion were
grown in YEP 2% raffinose and 2% galactose at 25°
C, and the percentage of cells with at least one
VHL-GFP focus (A) or more than one VHL-GFP focus
(B) was determined. n = 3. SEM is shown. n = 200 cells
per time point. (∗) P < 0.05; (∗∗∗) P < 0.001; (∗∗∗∗) P <
0.0001, Student’s t-test. The euploid ubp3Δ focus
level is indicated with the dotted line. (C ) The corre-
lation between the percentages of disomic ubp3Δ
cells harboring more than one VHL-GFP focus and
the doubling time increase of each disome upon
UBP3 deletion is plotted. (D) Cells were grown to
mid-log phase in YPD. Samples were taken before
the addition of 0.2 µg/mL rapamycin (t = 0) and after
2 and 3 h of drug treatment. The mobility of mCi-
trine-Atg8 was determined by Western blot analysis.
The slower-migrating form represents the uncleaved
mCitrine-Atg8 fusion. The faster-migrating form rep-
resents cleaved mCitrine. Kar2 was used as loading
control.
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Using an mCitrine-Atg8 reporter construct, we assessed
the capacity of disomes with and withoutUBP3 to induce
autophagy (Klionsky et al. 2014; Nair et al. 2014). In this
assay, cells whose endogenous Atg8 was N-terminally
tagged with mCitrine were grown in rich medium, and
autophagy was induced by the addition of rapamycin to
mimic starvation. Cleavage of mCitrine from the Atg8
protein occurs upon delivery of the fusion to the vacuole,
where Atg8 is rapidly degraded, andmCitrine remains rel-
atively stable (Shintani and Klionsky 2004). Therefore,
detection of free mCitrine reflects autophagic activity,
while the levels of themCitrine-Atg8 fusion reflect the in-
duction of endogenousATG8 expression. Importantly, the
disomes showed normal induction of autophagy in re-
sponse to rapamycin addition (Fig. 3D). The wild-type
strain lacking UBP3 exhibited mild autophagy defects,
as reported previously, but the ubp3Δ disomes remained
competent for autophagy (Fig. 3D). In fact, levels of Atg8
were elevated under basal conditions in the ubp3Δ
disomes (Fig. 3D, t = 0), indicating that deletion of UBP3
in the disomic strains does not interfere with auto-
phagy but rather induces proteotoxic stress that leads
to up-regulation of autophagy. These results support our
conclusion that the ubp3Δ disomes are under severe
proteotoxic stress and indicate that the autophagy path-
way may be increasingly relied on in the presence of
significantly compromised proteostasis in yeast. Thus,
Ubp3 is a pleiotropicDUBwith roles in cellular protection
from proteotoxic stress and acts as an aneuploidy-buffer-
ing protein whose deletion substantially exacerbates pro-
teotoxicity in aneuploid yeast.
Cells lacking UBP3 show hallmarks of impaired
proteasome function
Our results indicate that proteotoxicity is elevated in dis-
omes lacking UBP3. However, the molecular defect un-
derlying this phenotype was unclear. The clearance of
misfolded VHL proceeds through both Hsp70 and Hsp90
chaperones followed by degradation by the proteasome
(McClellan et al. 2005). Assessment of the in vivo folding
of the Hsp90 substrate Src tyrosine kinase can be achieved
by inducing expression of either c-src, which does not af-
fect proliferation of yeast cells, or v-src,whose overexpres-
sion is lethal in yeast (Xu and Lindquist 1993). In cells
with uncompromised Hsp90 activity, expression of v-src
is lethal due to proper folding of the toxic protein; when
Hsp90 activity is impaired, however, improved growth is
seen in v-src-expressing cells upon induction. Disomic
yeast are known to have reduced Hsp90 folding capacity
(Oromendia et al. 2012); however, UBP3 deletion caused
no enhancement of this phenotype (data not shown).
These findings indicate that deletion of UBP3 does not
impair proliferation of disomic yeast by further hampering
Hsp90 activity.
Whether Ubp3 was required for proteasome function
had not been explored previously. However, Isasa et al.
(2015) showed that cells lacking UBP3 accumulate ubiq-
uitylated proteins. We confirmed that deletion of UBP3
indeed leads to the accumulation of ubiquitylated pro-
teins, in contrast to deletion of other DUBs, exemplified
by the proteasome-inhibiting DUB Ubp6 (Fig. 4A; Isasa
et al. 2015). To begin to determine whether loss of UBP3
affected proteasome function, we deleted UBP3 in cells
carrying a temperature-sensitive allele of the gene encod-
ing a proteasome lid subunit, Rpn6 (Isono et al. 2005).
Deletion of UBP3 exhibits a strong synthetic fitness
defect when combined with the rpn6-1 allele (Fig. 4B,C).
This finding raises the possibility that UBP3 deletion
leads to impaired proteasome function.
Deletion of UBP3 increases the half-lives of proteasome
substrates
In order to more directly test the role of Ubp3 in protea-
some function, we assessed the half-lives of various ubiq-
uitin–proteasome substrates in the presence and absence
of UBP3. For these experiments, genes encoding ubiqui-
tin–proteasome substrates were placed under the control
of the galactose-inducible/glucose-repressible GAL1-10
promoter. Transcription was then induced for 45 min,
after which time transcription was repressed by glucose
addition. At the same time, cycloheximide was added to
prevent further translation. Protein levels were then mea-
sured by Western blotting to determine the half-lives of
various ubiquitin–proteasome substrates.
The first substrate that we examined was URL-Bub2-
HA, a fusion between a ubiquitin–arginine–lacZ (URL)
degron and the mitotic exit network protein Bub2 (Bach-
mair et al. 1986; Visintin et al. 2008). Exposure of an
Figure 4. Cells lacking UBP3 accumulate ubiquitylated pro-
teins and exhibit synthetic negative interactions with the hypo-
morphic proteasome mutant rpn6-1. (A) Cells were grown to
mid-log phase inYPD, and total ubiquitin conjugateswere detect-
ed using anti-ubiquitin antibody in Western blot analysis. Pgk1
was used as a loading control. (B) Doubling times of the indicated
strains were determined as described in Figure 1 at 25°C. P <
0.0001, Student’s t-test. (C ) Cultures of the strains in B were
grown overnight in YPD, and 10-fold serial dilutions were plated
on YPD plates at 25°C.
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arginine at the N terminus of a protein after cleavage of
the N-terminal ubiquitin moiety leads to rapid degrada-
tion of the protein by the N-end rule pathway (Bachmair
et al. 1986). Thus, the URL-Bub2-HA fusion is highly
unstable in wild-type cells, with a half-life of ∼1.5 min
(Fig. 5A,B). Upon deletion ofUBP3, degradation of the fu-
sion protein was substantially delayed, with the half-life
of this protein increasing to ∼8.5 min in the ubp3Δ strain
(Fig. 5A,B).
The secondubiquitin–proteasome substratewhose half-
life we determined was the transcription factor Gcn4.
Gcn4 protein levels are controlled by the SCF ubiquitin
ligase (Irniger and Braus 2003). This ubiquitin ligase
complex ubiquitylates substrates that have been phos-
phorylated previously (Willems et al. 2004). Using an in-
ducible Gcn4-lacZ fusion, we observed that deletion of
UBP3 significantly delayed the degradation of this con-
struct. Wild-type cells degraded the majority of Gcn4 by
5 min after cycloheximide addition, while ubp3Δ cells
required 30 min to reach similar levels (Fig. 5C,D).
Finally, we examined the half-life of Cdc20, whose deg-
radation depends on a ubiquitin ligase known as the ana-
phase-promoting complex or cyclosome (APC/C) (Prinz
et al. 1998; Barford 2010). Degradation of Cdc20-HA was
also delayed in cells lacking UBP3, with the estimated
half-life of this protein increasing from 6 to ∼10 min
in ubp3Δ cells (Fig. 5E,F). We conclude that the deubiqui-
tinase Ubp3 is required for the degradation of multiple
different ubiquitin/proteasome substrates in euploid
yeast cells.
Although cells lacking UBP3 display delayed degrada-
tion of a variety of proteasome substrates, each of which
enters the proteasome via distinct ubiquitylation path-
ways, the fundamental peptidase activities of the catalytic
core of the proteasome remain intact. Using fluorogenic
substrates, each of which is cleaved by one of the three
proteasome-resident peptidase activities, we determined
that ubp3Δ cell lysates are competent to cleave these pep-
tides with the same kinetics as wild type (Fig. 5G). This is
perhaps unsurprising, as a deubiquitinase ismore likely to
be involved in the regulation of the proteasome rather
than its peptidase activities, but themechanism bywhich
Ubp3 impinges on the proteasome remains unknown.
Aneuploid cells have impaired proteasome function
Previous work suggested that proteasomal degradation
was limiting in disomic yeast strains. Several disomes ex-
hibit sensitivity to the proteasome inhibitor MG132 (Tor-
res et al. 2007), and deletion of the gene encoding the
proteasome-inhibiting DUB Ubp6 was shown to improve
the proliferation of most disomic strains at high tempera-
tures (Dephoure et al. 2014). Gene expression analysis of
disomic strains further supports the conclusion that pro-
teasomal activity is limiting in aneuploid yeast. Under
standard growth conditions (batch growth), genes whose
Figure 5. Deletion of UBP3 increases the half-lives
of known ubiquitin–proteasome substrates without
affecting the in vitro catalytic activity of the protea-
some. (A–F ) Cells were grown overnight in medium
containing raffinose at room temperature, and expres-
sion of tagged substrates was induced by the addition
of 2% galactose for 45 min. The t = 0 sample was tak-
en before the addition of 2%glucose and 50 µg/mL cy-
cloheximide. Samples were taken at the indicated
times after cycloheximide addition, and protein lev-
els were analyzed by Western blot analysis. Quantifi-
cations relative to the loading control and normalized
to time = 0 are plotted in A, C, and E. (A,B) The half-
life of Bub2 in wild-type cells and cells lacking
UBP3. Vph1 was used as a loading control. (C,D)
The half-life of Gcn4 in wild-type cells and cells lack-
ing UBP3. Pgk1 was used as a loading control. (E,F )
The half-life of Cdc20 in wild-type cells and cells
lacking UBP3. Pgk1 was used as a loading control.
(G) The in vitro proteasome activity of UBP3 and
ubp3Δ cell lysates was determined using cleavage of
fluorogenic substrates as a readout for protease activ-
ity. MG132 was added to wild-type lysates to inhibit
the activity of two of the three peptidase activities
of the proteasome.
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expression changes according to the degree of aneuploidy
are predominantly involved in the environmental stress
response (ESR) or are otherwise known to vary according
to growth rate (Sheltzer et al. 2012). However, when the
disomes are grown under nutrient limitation in chemo-
stats to equalize proliferation between euploid and aneu-
ploid strains, the ESR gene signature is abolished (Torres
et al. 2007). In order to identify transcripts that vary ac-
cording to the degree of aneuploidy but are independent
of culture conditions, we combined gene expression data
from aneuploid strains grown in batch culture and under
doubling time-equalizing phosphate-limited conditions
in chemostats. Genes whose expression increased with
an increased degree of aneuploidy were strongly enriched
for subunits of the proteasome complex (P < 10−6) and oth-
er genes involved in proteolysis (P < 10−3) (Fig. 6A;
Supplemental Table 1). Indeed, proteasomal subunit
gene expression correlates strongly with degree of aneu-
ploidy, suggesting that proteasome function is limiting
in disomic cells (Fig. 6B,C).
To more directly test whether deletion ofUBP3 causes
a fitness defect in disomic yeast strains because it enhanc-
es an already existing protein degradation defect in aneu-
ploid cells, we determined the half-life of the SCF
substrate Gcn4 in two disomes, disomes XIV and XVI,
whose proliferation was severely impacted by deleting
UBP3, and in one disome, disome XI, whose fitness was
moderately affected by UBP3 deletion (Fig. 1C). The
half-life of Gcn4-lacZ was greatly increased in cells diso-
mic for either chromosome XIV or XVI while remaining
unchanged in disome XI cells (Fig. 6D). These findings
suggest that the protein degradation defect in disomes
XIV and XVI is so severe as to be apparent even in the pres-
ence of a functional UBP3 gene. In contrast, the protein
degradation defect of disome XI cells is too subtle to be
detected in protein half-life measurements and becomes
apparent only in cells lacking UBP3. Consistent with
this idea is the observation that the two disomies that
are synthetic lethal with deletion of UBP3—XII and XIV
—are also synthetic lethal with the rpn6-1 mutation
(Torres et al. 2010). Finally, the observation that deletion
of UBP6, which causes hyperactivation of the protea-
some (Hanna et al. 2006), partially rescues the pro-
liferation defects of disomic strains harboring a UBP3
deletion further supports this hypothesis (Fig. 6E). We
conclude that proteasome function is limiting in many
disomic yeast strains and propose that a further decrease
in proteasome function is the likely basis for much of
the fitness defect conferred by deletion of UBP3 on diso-
mic yeast strains.
Depletion of the human homolog of UBP3, USP10,
impairs proliferation of aneuploid human cells
Ubp3 is conserved. Its closest homolog in mammals is en-
coded by the USP10 gene (Soncini et al. 2001). To assess
whether the fitness defect conferred by UBP3 deletion
on aneuploid yeast is conserved in higher eukaryotes,
Figure 6. Disomic yeast strains show impaired protein degra-
dation and up-regulate proteasome gene expression. (A) The per-
centages of the geneswhose expression correlates with the degree
of aneuploidy (dark gray) and the percentages of all genes across
the genome (white) that belong to the gene ontology (GO) term
categories “proteasome” and “proteolysis” are plotted. (B) The
relative expression levels of proteasome component genes RPT5
andRPN1 in disomic strains grown in either batch culture or che-
mostats are plotted against the percent aneuploidy of each strain
(number of disomic ORFs/total number of yeast ORFs). Data are
from Torres et al. (2007). Linear regression values are shown.
(C ) Genes belonging to the GO term category “proteasome”
whose expression is correlated with the degree of aneuploidy
are listed along with the correlation coefficient for each gene.
(D) The experiment was performed as described for Figure 5,
A–F. Western blots show degradation of Gcn4-LacZ in wild type
and three disomes. Pgk1 was used as a loading control. (E) Dou-
bling times of the indicated strains were determined as described
in Figure 1.
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we treated euploid RPE-1 cells with siRNA to deplete
USP10 and induced chromosomemissegregation 24 h lat-
er by one of two methods. We treated RPE-1 cells with
reversine, an inhibitor of the spindle assembly checkpoint
(SAC) protein kinase Mps1, or depleted the SAC protein
Mad2 via siRNA (Santaguida et al. 2010). These two
methods lead to the missegregation of one or a few chro-
mosomes in the vast majority of cells (Santaguida et al.
2010, 2015). Induction of chromosome missegregation in
control RNAi-treated cells led to an ∼25% decrease in
cell viability (Fig. 7A). Depletion ofUSP10 led to a signifi-
cant further decrease in cell proliferation. Fewer than 50%
of cells survived the induction of chromosome missegre-
gation in the absence of USP10 (Fig. 7A; Supplemental
Fig. S4). Spautin-1, a compound that specifically inhibits
USP10 (Liu et al. 2011) caused an effect similar to that
of knockdown of the gene (Fig. 7B). Treatment of RPE-1
cells with this drug concurrent with induction of chromo-
some missegregation by Mad2 depletion led to a signi-
ficant decrease in cell number compared with cells in
which USP10 was not inhibited. This effect was indepen-
dent of the presence of a functional SAC; when the
aneuploid cell population was established by reversine
treatment but the drug was removed to reinstate the
SAC before spautin-1 treatment, the result was the same
(Fig. 7C). Finally, USP10 inhibition also inhibits the pro-
liferation of stable aneuploid cells; mouse embryonic fi-
broblasts (MEFs) trisomic for chromosome 13 or 16 were
more sensitive to spautin-1 treatment than their euploid
counterparts (Fig. 7D).
USP10 has been implicated previously in the regulation
of proteins involved in autophagy (Liu et al. 2011). Aneu-
ploid cells are under proteotoxic stress and have been
found to exhibit defects in autophagy-mediated protein
degradation (Ohashi et al. 2015; Santaguida et al. 2015).
Specifically, autophagic cargo accumulateswithin autoly-
sosomes following chromosome missegregation (Santa-
guida et al. 2015). This autophagic flux defect can be
assessed by analyzing the migration of the autophagic
vesicle protein LC3. To be incorporated into autophagic
vesicles, LC3 is cleaved and lipidated, resulting in the gen-
eration of the protein known as LC3-II. Accumulation of
LC3-II is thus indicative of the accumulation of autopha-
gosomes (Klionsky et al. 2014). Consistent with previous-
ly published results (Santaguida et al. 2015), we found that
cells induced to missegregate chromosomes by reversine
treatment harbored elevated levels of LC3-II relative to
euploid cells (Fig. 7E [lanes 1,2], F). Autophagic flux can
Figure 7. Depletion and inhibition of
USP10 impairs the growth of aneuploid hu-
man cells. (A) RPE-1 cells were treated with
siRNA targeting USP10 or control siRNA.
Twenty-four hours later, cells were treated
with eitherMAD2 siRNAor control siRNA
or reversine or solvent. Three days after
Mad2 siRNA or reversine treatment, cells
were harvested, and the number of cells
was determined. n = 3. Mean ± SD shown.
P < 0.05, Student’s t-test. (B) RPE-1 cells
were treated with siRNA targeting Mad2
or control siRNA. Twenty-four hours later,
cells were treated with spautin-1 or solvent
only. Three days after spautin treatment,
cells were harvested, and the number of
cells was determined. n = 3. Mean ± SD
shown. P < 0.01, Student’s t-test. (C ) RPE-
1 cells were treated with reversine or sol-
vent to induce chromosome missegrega-
tion. Twenty-four hours later, the drug
was washed out, and cells were treated
with spautin-1 or solvent. Three days after
spautin treatment, cells were harvested,
and the number of cells was determined.
n = 3. Mean ± SD shown, P = 0.0015, Stu-
dent’s t-test. (D) MEFs either euploid or tri-
somic for chromosome 13 or 16 were
treated with spautin-1 or solvent only. Three days after treatment, cells were harvested, and the number of cells was determined. n = 3.
Mean ± SD shown. P < 0.05, Student’s t-test. (E) RPE-1 cells were treated with spautin-1 or solvent. Twenty-four hours later, cells were
treatedwith reversine or solvent to induce chromosomemissegregation. Three days after reversine treatment, cellswere treatedwith Bafi-
lomycin A1 (BafA1) or solvent only and harvested 6 h later. LC3-I and LC3-II levels were analyzed by Western blot analysis. GAPDHwas
used as a loading control. (F ) Quantification of LC3-II levels in E were normalized to the untreated control (lane 1). (G) Levels of USP10
gene expression in matched normal and cancer cells were plotted. Data are from the Broad Institute GDAC Firehose. (BRCA) Breast-in-
vasive carcinoma; (COADREAD) colorectal adenocarcinoma; (HNSC) head and neck squamous cell carcinoma; (KIPAN) pan-kidney co-
hort; (LIHC) liver hepatocellular carcinoma; (LUAD) lung adenocarcinoma; (LUSC) lung squamous cell carcinoma; (PRAD) prostate
adenocarcinoma; (STAD) stomach adenocarcinoma. (∗) P < 0.0001.
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be assessed by comparing LC3-II levels between untreated
cells and cells treated with the lysosomal inhibitor Bafilo-
mycin A1 (BafA1) 6 h prior to harvesting. In cells with
compromised flux, the differential between LC3-II levels
treated with and without BafA1 is lower than that of cells
with normal flux. Using this metric, we confirmed that
autophagic flux is decreased following chromosome mis-
segregation (Fig. 7E,F; Santaguida et al. 2015).
While aneuploidy causes a decrease in autophagic flux,
spautin-1 prevents the formation of autophagosomes alto-
gether. Consistent with previously published findings, we
did not detect LC3-II in cells treated with the USP10
inhibitor irrespective of whether cells were induced to
missegregate chromosomes (Fig. 7E [lanes 3,4], F; Liu
et al. 2011). Even inhibition of lysosomal degradation by
BafA1 treatment did not lead to the accumulation of
LC3-II when USP10 was inhibited (Fig. 7E [lane 8], F).
Thus, aneuploid cells in which USP10 is inhibited are un-
able to generate autophagosomes and are thus blocked at
early stages of autophagy. Our results suggest that the in-
hibition of early stages of autophagosome formation in
aneuploid cells, which depend on autophagy for full via-
bility (Tang et al. 2011), contributes to the fitness defect
conferred by USP10 depletion or inhibition on aneuploid
cells. Consistent with the conclusion that USP10 is im-
portant for the survival of aneuploid cells, we found that
USP10 expression is elevated in an array of highly aneu-
ploid cancer types, including colorectal adenocarcinoma
and lung squamous cell carcinoma among others (Fig.
7G). We speculate that USP10 and other such aneuploi-
dy-tolerating proteins are overexpressed and relied on by
a variety of tumor types.
Discussion
In yeast and mammalian cells, increasing chromosome
copy number leads to a corresponding elevation in the lev-
els of proteins encoded on the duplicated chromosomes
(Williams et al. 2008; Pavelka et al. 2010; Torres et al.
2010; Dephoure et al. 2014). These proteins cause a pleth-
ora of cellular phenotypes dependent on both their specif-
ic identities and the sum of imbalanced proteins affecting
general homeostatic cellular pathways. The deubiquiti-
nase Ubp3 is integral to cellular homeostasis of aneuploid
yeast cells, allowing cells to tolerate both karyotype-spe-
cific and karyotype-independent effects of aneuploidy.
Deletion of UBP3 severely enhanced the secretion defect
of disome XVI cells, illustrating that deletion of this DUB
gene accentuates chromosome-specific phenotypes of
aneuploid cells. General deficiencies associated with
aneuploidy are also enhanced by loss of Ubp3 function.
Deletion of UBP3 impairs the efficiency of proteasomal
degradation and substantially enhances proteotoxicity in
aneuploid yeast. Proteotoxicity is not the only general
aneuploidy-associated stress enhanced by deletion of
UBP3. Whereas deletion of UBP3 in wild-type cells con-
ferred a mild sensitivity to the oxidative agent diamide,
all disomes except disome X exhibited significantly in-
creased sensitivity to the drug in the absence of UBP3
(Supplemental Fig. S5). We propose that pleiotropic pro-
teins such as Ubp3 are central to the survival of aneuploid
cells. Like aneuploidy, such proteins affect numerous cel-
lular functions, the impairment of which leads to synthet-
ic fitness defects when combined with multiple different
aneuploidies.
The deubiquitinase Ubp3 is required for efficient
proteasome function in yeast
Our data provide the first evidence for a general role of
Ubp3 in ubiquitin-mediated protein degradation. We
found that degradation ofmany different proteins targeted
by distinct ubiquitin ligases is stabilized in cells lacking
UBP3. While we cannot exclude the possibility that dele-
tion of UBP3 independently affects all ubiquitination
systems that we examined (e.g., by modulating the activ-
ity of the E1 enzyme Uba1), we favor the idea that UBP3
affects protein degradation at a step following ubiquityla-
tion. Consistent with this hypothesis is the observation
that ubiquitylated proteins accumulate in ubp3Δ cells
(Fig. 4A; Isasa et al. 2015). How Ubp3 contributes to the
degradation of ubiquitylated proteins remains to be deter-
mined. UBP3 could deubiquitinate many different sub-
strates. Indeed, previous studies have demonstrated roles
for Ubp3 in enhancing or delaying the degradation of par-
ticular substrates by direct deubiquitination (Brew and
Huffaker 2002; Cohen et al. 2003a; Kraft et al. 2008; Kvint
et al. 2008; Chew et al. 2010; Li and Wang 2013). Ubp3
could also affect the proteasome itself. A small fraction
of Ubp3 (5%) associates with the proteasome, and a direct
interaction between Ubp3 and proteasomal components
has been documented both in vitro and in vivo (Mao and
Smerdon 2010). It is thus possible that an as yet unidenti-
fied substrate of Ubp3 is important for promoting protea-
some function and that deletion of the DUB destabilizes
this proteasome activator, thereby decreasing overall pro-
teasome function. Indeed, the activity of the Rpn10 sub-
unit of the 19S proteasome regulatory particle has been
shown to be modulated by monoubiquitination, con-
trolled by the E3 ligase Rsp5 and its antagonist, the DUB
Ubp2 (Isasa et al. 2010). Perhaps Ubp3 plays a similar
role for a distinct proteasomal component or proteasomal
activator, thereby modulating the activity or stability of
an adaptor protein that delivers substrates to the regula-
tory particle or directly modulating the activity of the
regulatory particle itself. Such a mechanism would not
cause changes in the in vitro protease activity of the pro-
teasome core particle, providing an explanation for our
finding that this enzymatic activity remains unchanged
in ubp3Δ cell lysates. It will be important to determine
the exact mechanism by which Ubp3 promotes the degra-
dation of proteasome substrates given the central role of
this macromolecular machine in myriad cellular process-
es and disease states (Schmidt and Finley 2014).
It is noteworthy thatUbp3 is not the firstDUB implicat-
ed in controlling the survival of aneuploid cells. We found
previously that the DUBUbp6 affects the viability of diso-
mic yeast strains, especially at high temperatures (Torres
et al. 2010; Dephoure et al. 2014). However, unlike dele-
tion of UBP3, deletion of UBP6 enhanced rather than
Ubp3 confers aneuploidy tolerance
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impaired the viability of disomic yeast strains. This effect
was attributed to the role of Ubp6 in antagonizing protea-
some function. Ubp3, on the other hand, is required for
full proteasome function (this study), providing an expla-
nation for how twomembers of the same class of enzymes
can have opposite effects on the fitness of aneuploid cells.
Ultimately, both DUBs impact the UPS, indicating that
the proteasome is a highly sensitive molecular machine
whose proper regulation is integral to the viability of
aneuploid cells.
The Ubp3 homolog USP10 confers aneuploidy
tolerance in human cells
The detrimental effects of loss ofUBP3 function on aneu-
ploid cells are not confined to budding yeast. We found
that aneuploid cells generated by transient inhibition of
the SAC are sensitive to loss of function of the UBP3 ho-
mologUSP10. Whether loss of USP10 function synergizes
with the same aneuploidy-associated stresses in mam-
malian cells as in yeast cells remains to be determined.
To date, USP10 has not been implicated in proteasome
function in mammalian cells. However, like UBP3 in
yeast,USP10 has been reported to regulate numerous cel-
lular functions, including controlling the induction of
autophagy, sensing energy stress via AMPK, and regulat-
ing the stability of p53 (Yuan et al. 2010; Liu et al. 2011;
Deng et al. 2016). USP10 can thus also be considered a
pleiotropic hub protein that, like UBP3, impacts the fit-
ness of aneuploid mammalian cells in multiple ways.
One plausible mechanism by which loss of USP10 func-
tion negatively affects the fitness of aneuploid mammali-
an cells is through its role in autophagy. In this study, we
demonstrate that inhibition of USP10 impairs the ability
of both aneuploid and euploid cells to form autophago-
somes. Acutely aneuploid cells are known to experience
autophagic flux defects as well as display a lysosomal
stress response even under standard growth conditions
(Santaguida et al. 2015). Given the increased dependence
on autophagy of cells with unbalanced karyotypes (Tang
et al. 2011; Stingele et al. 2012; Santaguida et al. 2015),
this mechanism likely explains at least part of the growth
defect conferred by USP10 depletion on aneuploid cells.
Genome-wide screens in yeast have the potential to
identify therapeutic targets in cancer
It is exciting to note that a genome-wide genetic screen in
S. cerevisiae was successfully used to identify a key regu-
lator of aneuploid cell homeostasis that is conserved from
yeast to human cells. The conservation of the integral role
played by such a pleiotropic gene in aneuploid cells
suggests that highly pleiotropic hub genes may represent
a category of genes whose proper regulation is essential
to the ability of cells to tolerate the consequences of chro-
mosome missegregation and the resulting unbalanced
karyotypes. This conclusion is intriguing in terms of
both illustrating the utility of screens in model organisms
to illuminate mammalian cell biology and suggesting a
novel group of targets whose manipulation could be ex-
ploited therapeutically in aneuploid contexts.
Importantly, aneuploidy is a highly prevalent feature of
human cancers; >90% of solid tumors are reported to be
aneuploid (Beroukhim et al. 2010). Thus, inhibition of
USP10 or other pleiotropic regulatory proteins could be
a useful therapeutic strategy to preferentially inhibit the
proliferation of aneuploid cancer cells. In this regard, it
is exciting to note that USP10 expression levels are ele-
vated across an array of cancer types (Fig. 7G), potentially
indicating a reliance of these cells on the activity of this
pleiotropic DUB. However, it is important to note that
the specific role of USP10 in stabilizing p53will likely im-
pinge on the utility of targeting USP10; tumors with mu-
tant p53 may be more amenable to USP10 inhibition as a
therapeutic approach (Yuan et al. 2010).
Proteotoxic crisis is a key feature of cancer cells, likely
due to both an abundance ofmissensemutations and copy
number variation affecting cancer genomes (Deshaies
2014). For this reason, proteasome inhibitors have been
used successfully to treat cancers, including multiple
myeloma and mantle cell lymphoma, and aneuploid and
chromosomally unstable cancer cell lines are preferential-
ly sensitive to drugs interfering with protein folding,
autophagy, and HSF1 activation (Tang et al. 2011; Santa-
gata et al. 2013). Finally, inhibitors of the protein quality
control AAA ATPase p97 are preferentially cytotoxic to
cancer cells (Magnaghi et al. 2013; Chou et al. 2011). Ex-
citingly, the yeast homolog of p97, Cdc48, is an inter-
acting protein of Ubp3 (Ossareh-Nazari et al. 2010a,b),
further supporting the idea that the reliance of aneuploid
cells on Ubp3 function could be therapeutically relevant.
Thus, the identification of additional aneuploidy-tolerat-
ing genes will be a crucial approach to illuminate future
chemotherapeutic targets.
Materials and methods
Yeast strains and plasmids
Disomes used in this study are derivatives of those published in
Torres et al. (2007) or were generated using the same method.
De novo gene deletions were generated using published methods
(Longtine et al. 1998) in a wild-type W303 yeast strain. Disomes
carrying candidate gene deletions were constructed by crosses.
Karyotypes of key disomic strains were verified by comparative
genomic hybridization as described (Torres et al. 2007) and
were analyzed with Java TreeView. All strains are listed in
Supplemental Table 2.
Doubling time analysis
Cells were grown overnight at room temperature in yeast extract/
peptone medium containing 2% glucose (YPD) and diluted to
OD600 = 0.1 the next morning. The growth rate of these cultures
at either 25°C or 37°C was measured in triplicate using a BioTek
plate reader to take measurements every 15 min for 24 h. Data
were analyzed using Gen5 BioTek software. The period of expo-
nential growth was used to calculate doubling time using Graph-
Pad Prism software. Data shown are the average of three to eight
biological replicates performed on different days.
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Assessment of yeast drug sensitivity and fitness by serial
dilution
Overnight cultures in YPD were diluted to OD600 = 1.0, and 1.9
µL of 10-fold serial dilutions was spotted on YPD plates that con-
tained either 50 µg/mL Brefeldin A or 0.75 mM diamide. Drug
sensitivity plates were incubated for 2 d at 30°C before imaging.
Analysis of cellular proteotoxicity using the VHL-GFP reporter
The number of VHL-GFP foci was determined as described (Oro-
mendia et al. 2012). Strains harboring the GAL-VHL-GFP fusion
were grown at 25°C in YEP 2% raffinose and 2% galactose to
mid-log phase. Samples were fixed with 3.7% formaldehyde,
and the percentage of cells harboring VHL-GFP foci was deter-
mined. At least 300 cells were counted for each strain.
Protein half-life measurements
Cells were grown overnight in medium containing raffinose
(selective for the plasmid, if applicable) at room temperature.
Expression of tagged substrates was induced by the addition of
2% galactose for 45 min. The t = 0 sample was taken, followed
by addition of 2% glucose and 50 µg/mL cycloheximide. Samples
were taken at the indicated times after cycloheximide addition
and processed as described for Western blot analyses using either
8% or 10% SDS-PAGE.
Protein trafficking assay
Detection of Ccw14p intermediates was performed as described
previously (Dodgson et al. 2016). Cell cultures were grown in
YPD tomid-exponential phase prior to TCA extraction andWest-
ern blot analysis using 10% SDS-PAGE.
Western blot analyses
Yeast cell pellets were suspended in 2 mL of 5% trichloroacetic
acid, and, after incubation for 10 min at 4°C, pellets were washed
with acetone. Dried pellets were then suspended in 100 µL of
breakage buffer (50 mM Tris-HCl at pH 7.5, 1 mM EDTA, 2.75
mM DTT, Roche complete protease inhibitor), glass beads were
added, and cells were broken by beating for 5 min on a Biospec
minibead beater. SDS sample buffer (3×) was added, and samples
were boiled for 5 min and centrifuged briefly. Human cells were
lysed in lysis buffer (50 mM Tris- HCl at pH 7.4, 150 mM NaCl,
5 mMMgCl2, 1% Triton X-100, 0.5% NP-40, 10% glycerol, pro-
tease inhibitor cocktail [Roche], phosphatase inhibitor cocktail
[Roche]) for 30 min on ice. All lysates were loaded on 8%, 10%,
or 15% SDS–polyacrylamide gels for electrophoresis and trans-
ferred onto nitrocellulose membranes before probing with prima-
ry antibody. The primary antibodies used were as follows: mouse
anti-GFP (1:1000; Clontech, JL-8), mouse anti-HA (1:1000; Cova-
nce, HA.11), rabbit anti-Gcn4 (1:200; Santa Cruz Biotechnology,
FL-281), rabbit Ccw14 antiserum (1:1000) (Dodgson et al. 2016),
mouse anti-ubiquitin (1:4000; Santa Cruz Biotechnology, P4D1),
rabbit anti-LC3 (1:1000; Sigma), rabbit anti-Kar2 antiserum
(1:200,000) (Rose et al. 1989), mouse anti-Vph1 (1:4000; Abcam),
mouse anti-GAPDH (1:1000; Santa Cruz Biotechnology, G-9),
and mouse anti-Pgk1 (1:10,000; Molecular Probes, A-6457). The
secondary antibodies used were donkey anti-rabbit conjugated
to horseradish peroxidase (HRP) (1:5000; GE Healthcare,
NA934) and sheep anti-mouse conjugated to HRP (1:5000; GE
Healthcare, NA931). HRP conjugates were detected using
Amersham ECL Prime reagent according to the manufacturer’s
instructions.
Proteasome activity assay
Cells were grown to late exponential phase in YPD before pellet-
ing and snap-freezing. Cell pellets were broken in 200 µL of lysis
buffer (50 mM Tris HCl at pH 7.5, 150 mM NaCl, 5 mMMgCl2,
10% glycerol) with zirconia beads on a Biospec minibead beater
for 5 min. Lysates were clarified twice by centrifugation at
15,000 rpm for 5 min. Proteasome activity was assayed using
the proteasome activity fluorometric assay kit II (UBPBio) accord-
ing to the manufacturer’s instructions. Briefly, 150 µL of warmed
substrate (Suc-LLVY-AMC, Z-LLE-AMC, or Boc-LRR-AMC in
proteasome assay buffer) was added to thewells of a 96-well plate,
and 40 µL of 5mg/mLcell lysate or lysis bufferwas then added. To
inhibit proteasome function, 100 µMMG132 was used. Readings
were taken every minute for 20 min at 30°C in a BioTek plate
reader.
Transcriptional enrichment analysis
Microarray data from aneuploid yeast strains were acquired from
Torres et al. (2007). For each strain, genes annotated to disomic
chromosomes were excluded from consideration. To determine
the degree of aneuploidy in each strain, the number of ORFs
present on disomic chromosomes was divided by the total num-
ber of ORFs in the yeast genome. A Pearson correlation coeffi-
cient (PCC) was calculated between the expression level of each
gene and the percent aneuploidy in each strain. A PCC cutoff of
r = ±0.4629 (P < 0.01) was applied to identify genes whose expres-
sionwas correlated or anti-correlatedwith increasing aneuploidy.
Gene ontology termswere identified usingGProfiler with a P-val-
ue threshold of 10−3 (Reimand et al. 2016).
Mammalian cell culture conditions and drug treatments
Cell lines were cultured in DMEM (Invitrogen) supplemented
with 10% FBS, 2 mM L-glutamine, and 100 U/mL penicillin/
streptomycin.Cellswere grown at 37°Cwith 5%CO2 in a humid-
ified environment. For experiments involving drug treatments,
controls represent cells treated with vehicle alone. Reversine
was obtained from Cayman Chemical, and Spautin-1 and BafA1
were purchased from Sigma-Aldrich.
RNAi
Silencer select siRNA oligos to knock down USP10 and MAD2
were purchased from Life Technologies and transfected using
RNAiMAX (Invitrogen).
Cell viability counting
To determine the degree of cell proliferation following induction
of chromosome missegregation, cells were harvested after 3 d of
Mad2 siRNA or reversine treatment to determine cell number
using the Cellometer AutoT4 (Nexcelom).
Analysis ofUSP10 gene expression in large-scale cancer data sets
RNA sequencing data were downloaded from the Broad Institute
GDAC Firehose (https://gdac.broadinstitute.org). Normalized
read counts from tumor and normal specimens were compared
using a Mann-Whitney U-test.
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